MAKO Surgical, a medical device company that markets products for minimally invasive orthopedic procedures, has reported fourth quarter 2010 revenue of $14.8 million, representing a 67 percent increase over the same period in 2009, according to a company news release.
President and CEO of MAKO Maurice Ferre, MD, attributes the increase in revenue to significant sales of its RIO systems and increased MAKOplasty procedure volume. In 4Q 2010 alone, 13 RIO systems were installed. Also during 4Q 2010, 1,146 MAKOplasty procedures were performed, representing a 104 percent increased over procedures performed in 4Q 2009.
Read the company news release about MAKO's 4Q financial results.
Read other coverage about device company financial reports:
- Exactech Announces 4Q Revenue of $51.8M, 7% Increase
- TranS1 Reports 4Q Revenue of $5.9M, 6% Decrease
- Integra LifeSciences Reports $194.1M 4Q Revenue, 6% Increase
President and CEO of MAKO Maurice Ferre, MD, attributes the increase in revenue to significant sales of its RIO systems and increased MAKOplasty procedure volume. In 4Q 2010 alone, 13 RIO systems were installed. Also during 4Q 2010, 1,146 MAKOplasty procedures were performed, representing a 104 percent increased over procedures performed in 4Q 2009.
Read the company news release about MAKO's 4Q financial results.
Read other coverage about device company financial reports:
- Exactech Announces 4Q Revenue of $51.8M, 7% Increase
- TranS1 Reports 4Q Revenue of $5.9M, 6% Decrease
- Integra LifeSciences Reports $194.1M 4Q Revenue, 6% Increase